Bleakley Financial Group’s Instil Bio TIL Stock Holding History

Bleakley Financial Group’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-553	Closed	-$7.3K	–	981
2023 Q1	$7.3K	Buy	+553	New	+$8.17K	﹤0.01%	907

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bleakley Financial Group's TIL Position: Q2 2023 in Review

Bleakley Financial Group sold out of Instil Bio (TIL) in Q2 2023, closing a stake of 553 shares — an estimated $7.3K sold.

Bleakley Financial Group first reported a position in TIL in Q1 2023 and held it in 1 quarter. The position peaked at $7.3K in Q1 2023. 62 funds tracked by Wall St. Rank hold TIL as of Q2 2023.

Bleakley Financial Group reported no remaining Instil Bio position as of Q2 2023 after selling out during the quarter.
Bleakley Financial Group sold 553 Instil Bio shares in Q2 2023, an estimated $7.3K.
Bleakley Financial Group first reported a position in Instil Bio in Q1 2023 and held it in 1 quarter.
Bleakley Financial Group's Instil Bio position peaked at $7.3K in Q1 2023.
62 funds tracked by Wall St. Rank held Instil Bio as of Q2 2023.

Based on Bleakley Financial Group's 13F filing for Q2 2023, filed 14 Aug 2023.